Skip to Content Skip to Navigation

About us Practical matters How to find us prof. dr. E.P. (Eugène) van Puijenbroek

prof. dr. E.P. (Eugène) van Puijenbroek

endowed professor of pharmacovigilance

Faculty of Science and Engineering

Telephone:

+31 50 36 34360

+31 50 36 37576 (Secretariaat)

Netherlands Pharmacovigilance Centre Lareb:

+31 73 646 9700 (Secretariaat)

e.vanpuijenbroek lareb.nl

E-mail:

e.p.van.puijenbroek rug.nl

ORCID Research Portal

Publications

Burden of non-serious infections during biological use for rheumatoid arthritis

Bergmans, B., Jessurun, N., van Lint, J., Murk, J-L., van Puijenbroek, E. & de Vries, E., 2024, In: PLoS ONE. 19, 2, 16 p., e0296821.

Research output: Contribution to journal › Article › Academic › peer-review

Improving Data Collection in Pregnancy Safety Studies: Towards Standardisation of Data Elements in Pregnancy Reports from Public and Private Partners, A Contribution from the ConcePTION Project

Favre, G., Richardson, J. L., Moore, A., Geissbühler, Y., Jehl, V., Oliver, A., Shechtman, S., Diav-Citrin, O., Berlin, M., De Haan, T., Baud, D., Panchaud, A., Mor, A., Sabidó, M., de Souza, S., Chambers, C., van Rijt-Weetink, Y. R. J., van Puijenbroek, E. P., Yates, L. M., Girardin, F., & 2 othersStellfeld, M. & Winterfeld, U., Mar-2024, In: Drug Safety. 47, p. 227–236 10 p.

Research output: Contribution to journal › Article › Academic › peer-review

Medication errors by caregivers in the homes of children discharged from a pediatric department in Ghana

Sabblah, G. T., van Hunsel, F., Taxis, K., Duwiejua, M., Seaneke, S. K. & van Puijenbroek, E., 2024, In: Therapeutic advances in drug safety. 15, 13 p.

Research output: Contribution to journal › Article › Academic › peer-review

Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis

Raschi, E., Salvo, F., Bate, A., De Ponti, F., Poluzzi, E., Tuccori, M., van Puijenbroek, E., Joshi, N. & Khouri, C., 18-Mar-2024, (E-pub ahead of print) In: Drug Safety. 5 p.

Research output: Contribution to journal › Editorial › Academic › peer-review

Validation of a Novel Method to Assess the Clinical Quality of Information in Pregnancy-Related Pharmacovigilance Case Reports: A ConcePTION Project

van Rijt-Weetink, Y. R. J., Egberts, T. C. G., van Hunsel, F. P. A. M., Lewis, D. J., Yates, L. M., Winterfeld, U. & van Puijenbroek, E. P., Mar-2024, In: Drug Safety. 47, p. 261-270 10 p.

Research output: Contribution to journal › Article › Academic › peer-review

A case series of bacillus Calmette-Guérin scar reactivation after administration of both mRNA and viral vector COVID-19 vaccines

van Balveren, L., van Puijenbroek, E. P., Davidson, L. & van Hunsel, F., Jul-2023, In: British Journal of Clinical Pharmacology. 89, 7, p. 2113-2121 9 p.

Research output: Contribution to journal › Article › Academic › peer-review

Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION Project

Richardson, J. L., Moore, A., Bromley, R. L., Stellfeld, M., Geissbühler, Y., Bluett-Duncan, M., Winterfeld, U., Favre, G., Alexe, A., Oliver, A. M., van Rijt-Weetink, Y. R. J., Hodson, K. K., Rezaallah, B., van Puijenbroek, E. P., Lewis, D. J. & Yates, L. M., 28-Mar-2023, In: Drug Safety. 46, 5, p. 479-491 13 p.

Research output: Contribution to journal › Review article › peer-review

Development of a Framework Structuring Themes in the Course of Adverse Drug Reactions from a Patient's Perspective

van Lint, J. A., Sonnenberg, M., Vonkeman, H. E., van den Bemt, B. J. F., van Puijenbroek, E. P. & Jessurun, N. T., 2023, In: Drug Safety. 46, p. 1039–1047 9 p.

Research output: Contribution to journal › Article › Academic › peer-review

Dilemma of belimumab therapy (dis)continuation during pregnancy: Results of a retrospective study in eudravigilance

Ghalandari, N., Crijns, H. J. M. J., Dolhain, R. J. E. M., Hazes, J. M. W. & van Puijenbroek, E. P., Feb-2023, In: Lupus. 32, 2, p. 189-197 9 p.

Research output: Contribution to journal › Article › Academic › peer-review

Disease-specific ADRs of TNF-α inhibitors as reported by patients with inflammatory rheumatic diseases: a registry-based prospective multicenter cohort study

Roest, L. H., Kosse, L. J., van Lint, J. A., Gosselt, H. R., Scholl, J. H. G., van Puijenbroek, E., Vonkeman, H. E., Tas, S. W., Nurmohamed, M. T., van den Bemt, B. J. F. & Jessurun, N. T., 2023, In: Expert Opinion on Drug Safety. 22, 3, p. 203-211 9 p.

Research output: Contribution to journal › Article › Academic › peer-review

All (326) publications

Press/media

Hoe weet je of een depressie het gevolg is van medicatie?

Eugène Puijenbroek, van

24/11/2016

Press/Media: Expert Comment › Popular

All (1) press/media

View full research profile

Follow the UGfacebook twitter linkedin rss instagram youtube